Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 2
1964 1
1968 1
1981 1
1985 1
1988 1
1991 1
1992 2
1993 2
1994 1
1995 1
1997 2
1998 3
1999 3
2000 2
2001 8
2002 2
2003 9
2004 5
2005 4
2006 7
2007 9
2008 3
2009 5
2010 2
2011 9
2012 5
2013 19
2014 9
2015 6
2016 4
2017 6
2018 4
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23649414

144 results
Results by year
Filters applied: . Clear all
Page 1
Drug patents: the high price of watchdog litigation.
Collier R. Collier R. CMAJ. 2013 Jun 11;185(9):E387-8. doi: 10.1503/cmaj.109-4474. Epub 2013 May 6. CMAJ. 2013. PMID: 23649414 Free PMC article. No abstract available.
On access and accountability--two Supreme Court rulings on generic drugs.
Boumil MM, Curfman GD. Boumil MM, et al. N Engl J Med. 2013 Aug 22;369(8):696-7. doi: 10.1056/NEJMp1308368. Epub 2013 Aug 7. N Engl J Med. 2013. PMID: 23923990 No abstract available.
Preliminary injunctions in generic and branded patent litigation.
Cohen S, England P. Cohen S, et al. Expert Opin Ther Pat. 2013 Sep;23(9):1083-6. doi: 10.1517/13543776.2013.819346. Epub 2013 Jul 16. Expert Opin Ther Pat. 2013. PMID: 23855903 No abstract available.
Drug patent protection: how long is long enough?
Sibbald B. Sibbald B. CMAJ. 2001 May 1;164(9):1331. CMAJ. 2001. PMID: 11341146 Free PMC article. No abstract available.
Limiting "evergreening" for a better balance of drug innovation incentives.
Stanbrook MB. Stanbrook MB. CMAJ. 2013 Aug 6;185(11):939. doi: 10.1503/cmaj.130992. Epub 2013 Jul 22. CMAJ. 2013. PMID: 23877665 Free PMC article. No abstract available.
144 results
Jump to page
Feedback